Antman, Karen
Molecular Targeting in Oncology
I.General Strategies for Molecular Targeting in Oncology
1. The Cell Cycle
Chad D. Knights, Richard G. Pestell
2. mTOR
John B. Easton, Peter J. Houghton
3. Ras/Raf/MEK Inhibitors
Joseph A. Sparano
4. 17-AAG
Len Neckers, Percy Ivy
5. The Cancer Epigenome
Sam Thiagalingam, Douglas V. Faller
II.Molecular Targeting for Specific Disease Sites
6. Molecular Targeting in Upper Gastrointestinal Malignancies
Scott Wadler
7. Molecular Targeting of Colorectal Cancer
Mark L. Sundermeyer, Alfonso Bellacosa, Neal J. Meropol
8. Molecular Targeting in Hepatocellular Carcinoma
Jonathan D. Schwartz, Josep M. Llovet
9. Molecularly Targeted Therapy in Pancreatic Cancer
Anupama Goel, Peter Kozuch
10. Untargeted Use of Targeted Therapy
Cheryl Ho, Angela M. Davies, Primo N. Lara, O. Gautschi, P.C. Mack, Paul H. Gumerlock, David R. Gandara
11. Renal Cell Carcinoma
Olwen Hahn, Walter Stadler
12. Targeted Therapies for Prostate Cancer
Elisabeth I. Heath, Michael A. Carducci
13. Molecular Targets in Ovarian Cancer and Endometrial Cancer
Nilofer S. Azad, Gisele Sarosy, Elise C. Kohn
14. Targeted Therapy For Breast Cancer
Deena M. Atieh, Linda T. Vahdat
15. Melanoma
Akshay Gupta, John M. Kirkwood
III.Classes of Drugs for Molecular Targeting in Oncology
16. Antibody Therapy of Cancer
Hossein Borghaei, Liat Binyamin, Igor Astsaturov, Louis M. Weiner
17. Nucleic Acid Therapies for Cancer Treatment
Dan T. Vogl, Alan M. Gewirtz
18. Engineering Oncolytic Measles Viruses for Targeted Cancer Therapy
Takafumi Nakamura, Stephen J. Russell
19. Vaccines as Targeted Cancer Therapy
Miguel-Angel Perales, Jedd D. Wolchok, Howard L. Kaufman
20. Cytokine-Based Therapy for Cancer
Henry B. Koon, Michael B.Atkins
21. Cyclooxygenase-2 as a Target for Cancer Prevention and Treatment
Monica Bertagnolli, Jaye L. Viner, Ernest T. Hawk
IV.Specific Drugs for Molecular Targeting in Oncology
22. Imatinib Mesylate (Gleevec®) and the Emergence of Chemotherapeuticss Drug-Resistant Mutations
Gerald V. Denis
23. Development of a Targeted Treatment for Cancer
John Mendelsohn
24. VEGF Inhibition for Cancer Therapy
Shermini Saini, Herbert Hurwitz
25. Somatostatin Analogue Therapy
M. C. Champaneria, I. M. Modlin, I. Latich, J. Bornschein, I. Drozdov, M. Kidd
V.Challenges in Molecular Targeting in Oncology
26. Patient Selection for Rational Development of Novel Anticancer Agents
Grace K. Dy, Alex A. Adjei
27. Clinical Trial Design with Targeted Agents
Sarita Dubey, Joan H. Schiller
28. How to Define Treatment Success or Failure if Tumors Do Not Shrink
J.J.E.M. Kitzen, M.J.A. de Jonge, J. Verweij
29. Molecular Imaging in Oncology
Lalitha K. Shankar, Anne Menkens, Daniel C. Sullivan
30. Combinations of Molecular-Targeted Therapies
Helen X. Chen, Janet E. Dancey
31. Preclinical Development of Molecularly Targeted Agents in Oncology
Joseph E. Tomaszewski, James H. Doroshow
DRM-restrictions
Printing: not available
Clipboard copying: not available
- Author(s)
- Antman, Karen
- Kaufman, Howard L.
- Wadler, Scott
- Publisher
- Springer
- Publication year
- 2008
- Language
- en
- Edition
- 1
- Category
- Medicine, Health Care, Mode
- Format
- Ebook
- eISBN (PDF)
- 9781597453370